2202 completed, 548 unknown, 467 recruiting, 281 terminated. 1399 Not applicable, 597 Phase 2, 393 Phase 3, 359 Phase 1, 233 Phase 4.
Follow Demyelinating Diseases: new trials by email Literature Review of Demyelinating Diseases trials Research Report on Demyelinating Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Vigorous Versus Low Intensity Cool Room Treadmill Training in People with Multiple Sclerosis Body-weight supported treadmill training in a room cooled to 16°C - Multiple Sclerosis, Neurological Rehabilitation | Not applicable | Withdrawn | Memorial University of Newfoundland | 2030-01-01 | 2024-11-27 | |
| Blood Biomarkers for Prognostic Stratification in Guillain-Barré Syndrome Blood Biomarker Panel Assessment (EGR1, EGR2, GBP1, miR-29c, and Piccolo) - Guillain Barré Syndrome | Recruiting | Anahuac University | 140 | 2027-12-01 | 2026-11-13 | |
| Inductive Therapeutic Exercise in Multiple Sclerosis Experimental: Inductive Therapeutic Exercise (ETI), Control: Sham Inductive Therapeutic Exercise (sham-ETI) - Multiple Sclerosis | Not applicable | Not yet recruiting | Fundación San Juan De Dios | 30 | 2027-10-01 | 2026-10-02 |
| Exploring Reproductive Decision-Making Among Women With Multiple Sclerosis Multiple Sclerosis | Not yet recruiting | Assiut University | 272 | 2027-06-01 | 2026-09-21 | |
| IT and IV Lentiviral Gene Therapy for X-ALD Intrathecal and intravenous LV gene therapy - X-linked Adrenoleukodystrophy | Not applicable | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 30 | 2027-06-01 | 2026-11-02 |
| Lentiviral Hematopoietic Stem Cell Gene Therapy for MLD Lentiviral TYF-ARSA correction of patient's autologous HSCs - Metachromatic Leukodystrophy (MLD) | Not applicable | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 10 | 2027-06-01 | 2026-11-02 |
| Direct Lentiviral Injection Gene Therapy for MLD Intrathecal and intravenous LV gene therapy - Metachromatic Leukodystrophy (MLD) | Not applicable | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 10 | 2027-05-31 | 2026-11-02 |
| A Study of Remibrutinib Using MR Imaging in Relapsing or Progressive MS Remibrutinib (Open Label) - Multiple Sclerosis (MS) - Relapsing-remitting, Multiple Sclerosis (MS) Secondary Progressive | Phase 2 | Not yet recruiting | Moein Amin | 20 | 2027-03-01 | 2026-08-19 |
| A Multicenter Phase 1 Study of Orca-Q in Primary Progressive Multiple Sclerosis Orca-Q, myeloablative regimen, Tacrolimus - Primary Progressive Multiple Sclerosis, Multiple Sclerosis | Phase 1 | Not yet recruiting | Orca Biosystems, Inc. | 10 | 2027-03-01 | 2026-11-13 |
| A Study to Investigate Long-term Safety and Tolerability of Frexalimab in Participants With Multiple Sclerosis Frexalimab, Frexalimab Placebo, Teriflunomide - Multiple Sclerosis | Phase 3 | Not yet recruiting | Sanofi | 2500 | 2027-02-15 | 2026-11-12 |
| C-CAR168, an Autologous Anti-CD20/BCMA Chimeric Antigen Receptor T-Cell Therapy, in Participants With Progressive Multiple Sclerosis Refractory to Standard Therapy C-CAR168 - Multiple Sclerosis, Primary Progressive Multiple Sclerosis | Phase 1 / Phase 2 | Not yet recruiting | AbelZeta Inc. | 119 | 2027-02-01 | 2026-10-13 |
| A Study to Evaluate the Long-term Safety and Efficacy of Fenebrutinib in Participants With Multiple Sclerosis (MS) Fenebrutinib - Multiple Sclerosis | Phase 3 | Not yet recruiting | Hoffmann-La Roche | 1800 | 2027-01-18 | 2026-11-16 |
| Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy UPLIZNA - Neuromyelitis Optica Spectrum Disorder, Pregnancy Related | Recruiting | Amgen | 60 | 2027-01-15 | 2026-10-29 | |
| Efficacy of Seated Physical Activity INtervention(SPIN) for Wheelchair Users With Multiple Sclerosis SPIN exercise-training, Control Condition (WELL) - Multiple Sclerosis | Not applicable | Not yet recruiting | The University of Texas Health Science Center, Houston | 100 | 2027-01-04 | 2026-10-23 |
| Exercise With and Without Cognitive Training Effect of Exercise with and Without Cognitive Training on Gait - Multiple Sclerosis | Not applicable | Not yet recruiting | VA Office of Research and Development | 30 | 2027-01-04 | 2026-03-03 |
| Cell-Based Therapy for White Matter Repair in Periventricular Leukomalacia Investigational Combination Product - Periventricular Leukomalacia, White Matter Disease | Early Phase 1 | Withdrawn | MGAM LLC | 2027-01-01 | 2025-07-22 | |
| An Open-label Phase I/II Safety and Feasibility Basket Study of UKT-CART19.1 CAR-T cells targeting CD19 - Pemphigus Vulgaris (PV), ANCA Associated Vasculitis (AAV) | Phase 1 / Phase 2 | Not yet recruiting | University Hospital Tuebingen | 36 | 2027-01-01 | 2026-11-12 |
| A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum Disorders Nabiximols, Placebo - NMO Spectrum Disorder, Spasticity, Muscle | Phase 2 | Withdrawn | Michael, Levy M.D.,Ph.D. | 2026-12-31 | 2025-07-16 | |
| Lead Exposure and Multiple Sclerosis Multiple Sclerosis | Not yet recruiting | Assiut University | 140 | 2026-12-30 | 2026-02-20 | |
| Local Vibration and Ankle Mobilization in Multiple Sclerosis Local Vibration, Ankle Joint Mobilization - Multiple Sclerosis | Not applicable | Not yet recruiting | Gaziantep Islam Science and Technology University | 60 | 2026-12-15 | 2026-10-19 |
Showing 20 of 4074. Sign in to see all of them.
Multiple Sclerosis (3168) · Multiple Sclerosis, Relapsing-Remitting (617) · Multiple Sclerosis, Chronic Progressive (244) · Fatigue (213) · Motor Activity (174) · Neuromyelitis Optica (172) · Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (136) · Stroke (110) · Parkinson Disease (99) · Guillain-Barre Syndrome (98) · Autoimmune Diseases (78) · Muscle Spasticity (78) · Cognitive Dysfunction (75) · Spinal Cord Injuries (74)
Nervous System Diseases (4007) · Immune System Diseases (3908) · Autoimmune Diseases of the Nervous System (3863) · Autoimmune Diseases (3839) · Demyelinating Autoimmune Diseases, CNS (3684) · Pathological Conditions, Signs and Symptoms (1191) · Pathologic Processes (689) · Disease Attributes (601) · Signs and Symptoms (574) · Chronic Disease (511) · Central Nervous System Diseases (488) · Brain Diseases (414) · Multiple Sclerosis (401) · Neurologic Manifestations (352)
Interferon beta-1a (107) · ocrelizumab (82) · Exercise (72) · Dimethyl Fumarate (70) · Natalizumab (67) · Interferon beta-1b (64) · Fingolimod Hydrochloride (58) · Glatiramer Acetate (55) · Rituximab (43) · teriflunomide (41) · Blood Specimen Collection (40) · Methylprednisolone (40) · Alemtuzumab (35) · 4-Aminopyridine (34) · ofatumumab (33)
Biogen (165) · Novartis Pharmaceuticals (94) · Merck KGaA, Darmstadt, Germany (49) · Bayer (47) · Assiut University (42) · Hoffmann-La Roche (41) · National Institute of Neurological Disorders and Stroke (NINDS) (36) · Sanofi (36) · Hasselt University (34) · Assistance Publique - Hôpitaux de Paris (33) · Johns Hopkins University (33) · Kessler Foundation (32) · Fondazione Don Carlo Gnocchi ETS (30) · Cairo University (28) · University of Washington (28)
United States (1493) · France (499) · Italy (386) · Germany (374) · Turkey (Türkiye) (347) · United Kingdom (333) · Canada (322) · Spain (301) · Poland (206) · Belgium (200) · Czechia (182) · Switzerland (168) · Denmark (150) · Netherlands (146) · China (141)
Daniel S Reich, M.D. (11) · Cagla Ozkul (9) · Michael Levy, MD, PhD (9) · Peter Feys, prof. dr. (9)
PMID 31072380, PMID 21387374, PMID 33023488, PMID 32447743, PMID 34882037, PMID 42578463, PMID 23669008, PMID 25475413, PMID 27411694, PMID 27733070, PMID 29275977, PMID 30918100, PMID 31654272, PMID 31762387, PMID 32710396, PMID 36163349, PMID 37652990, PMID 37745914, PMID 39935588, PMID 40258203, PMID 40756531, PMID 40966534, PMID 42328798, PMID 6685237, PMID 12525714, PMID 21586746, PMID 22622860, PMID 23531349, PMID 24131282, PMID 25245812, PMID 26932146, PMID 28002679, PMID 28002688, PMID 28825348, PMID 30144037, PMID 31675266, PMID 32426039, PMID 32539719, PMID 33332761, PMID 33414927, PMID 34035833, PMID 34376508, PMID 34378446, PMID 35003076, PMID 36619856, PMID 37272540, PMID 39251561, PMID 39383458, PMID 40743487, PMID 42368888
2023 (26), 2014 (22), 2015 (21), 2018 (19), 2019 (18), 2016 (16), 2017 (15), 2009 (13), 2008 (12), 2025 (10), 2005 (6), 2004 (3), K23AT004433 (2), K24AT012644 (2), P30DK056336 (2)